gemcitabine has been researched along with Extranodal NK-T-Cell Lymphoma in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 26 (70.27) | 24.3611 |
| 2020's | 11 (29.73) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Huo, J; Jin, M; Li, Z; Zhang, M | 1 |
| Wang, L | 1 |
| Wang, X; Young, KH; Zhang, M | 1 |
| Bachy, E; Cartron, G; Chaubard, S; Chauchet, A; Clavert, A; Couronné, L; Damaj, G; Fornecker, LM; Gaulard, P; Ghesquières, H; Gressin, R; Hermine, O; Jaccard, A; Lavergne, D; Le Gouill, S; Lemonnier, F; Marouf, A; Michot, JM; Obéric, L; Rossignol, J; Salles, G; Sibon, D; Tournilhac, O; Vargaftig, J; Waultier-Rascalou, A | 1 |
| Fu, R; Liang, Y; Liu, X; Piao, Y; Wang, L; Wei, L | 1 |
| Chai, Y; Chen, B; Dong, M; Fang, H; Li, YX; Liu, WP; Liu, WX; Qi, F; Qi, SN; Song, YQ; Wang, WH; Wei, YC; Xie, Y; Zhang, CG; Zhang, D; Zheng, BM; Zhu, J | 1 |
| Cai, H; Cao, X; Chen, M; Feng, J; Mao, Y; Wang, W; Wei, C; Yang, C; Zhang, L; Zhang, W; Zhang, Y; Zhou, D | 1 |
| Chen, Q; Dong, M; Wu, S; Yang, Z; Zhang, M; Zhang, X | 1 |
| Chang, Y; Fu, X; Li, L; Li, W; Li, X; Nan, F; Sun, Z; Wang, G; Wang, X; Wang, Y; Wu, J; Wu, X; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X; Zhou, Z | 1 |
| Cai, X; Chao, H; Chen, M; Jiang, Y; Lu, X | 1 |
| Qiu, C; Wang, L | 1 |
| He, JQ; Huang, LJ; Li, J; Li, JW; Li, KL; Li, YJ; Liu, XL; Liu, XY; OuYang, Z; Sun, ZY; Yi, PY; Zhong, MZ; Zhou, F; Zhou, H | 1 |
| Chen, B; Dong, M; Fang, H; Gui, L; He, XH; Li, YX; Liu, P; Qi, F; Qi, SN; Song, YW; Wang, SL; Wang, WH; Yang, JL; Yang, S; Zhou, SY | 1 |
| Cao, JZ; Chen, B; He, X; Hou, XR; Lan, SM; Li, YX; Liu, X; Qi, SN; Qian, LT; Qu, BL; Shi, M; Su, H; Wang, Y; Wu, G; Wu, JX; Wu, T; Xu, LM; Yang, Y; Yuan, ZY; Zhang, FQ; Zhang, LL; Zhang, YJ; Zhu, SY; Zhu, Y | 1 |
| Liang, T; Liu, Z; Yang, C; Yang, D; Zheng, Y | 1 |
| Chen, B; Dong, M; Fang, H; Gui, L; Li, Y; Lin, X; Liu, P; Qi, F; Qi, S; Song, Y; Wang, J; Wang, S; Yang, J; Yang, S; Zhou, S | 1 |
| Ahn, YO; Heo, DS; Kim, DW; Kim, S; Kim, TM; Lee, SH | 1 |
| Chan, JK; Chan, KH; Kwong, YL; Pang, AW; So, JC | 1 |
| Chang, Y; Fu, XR; Li, L; Li, X; Qiu, YJ; Sun, ZC; Wang, R; Wang, XH; Wu, JJ; Zhang, C; Zhang, L; Zhang, MZ | 1 |
| Lu, Y; Wang, L; Wang, WD; Xia, ZJ; Xiang, J; Zhang, YJ | 1 |
| Chang, H; Chen, X; Dai, Y; Dong, T; He, C; Ji, J; Li, J; Liu, T; Liu, W; Xiang, B | 1 |
| Chang, Y; Chen, C; Fu, X; Li, L; Li, X; Li, Z; Lu, L; Ma, W; Qin, B; Sun, Z; Wang, X; Wen, J; Wu, J; Yan, J; Zhang, L; Zhang, M; Zhang, X; Zhou, Z | 1 |
| Chen, X; Li, S; Lu, Y; Wang, H; Wang, KF; Wang, Z; Wuxiao, ZJ; Xia, ZJ; Zhu, J | 1 |
| Dong, M; Gui, L; He, X; Liu, P; Qin, Y; Shi, Y; Sun, Y; Yang, J; Yang, S; Zhang, C; Zhou, S | 1 |
| Bi, XW; Huang, JJ; Jiang, WQ; Li, ZM; Liu, PP; Sun, P; Wang, Y; Xia, Y; Zhang, WW | 1 |
| Hu, YP; Jiang, W; Liu, CC; Wang, WD; Xia, ZJ; Zhang, J | 1 |
| Li, Z; Lu, L; Sun, Z; Wang, Y; Zhang, M; Zhang, X; Zhou, Z | 1 |
| Chang, Y; Cui, Y; Fu, X; Li, L; Li, W; Li, X; Ma, W; Nan, F; Su, L; Sun, Z; Wang, J; Wang, X; Wu, J; Xue, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Huang, HQ; Jiang, WQ; Lu, Y; Wang, H; Wang, JH; Wang, YJ; Xia, ZJ | 1 |
| Huang, HQ; Jiang, WQ; Lin, TY; Liu, CC; Lu, Y; Wang, JH; Wang, L; Xia, ZJ | 1 |
| Jing, XM; Li, L; Luo, L; Ren, YR; Wei, W; Wu, P; Xiong, ZJ; Zhang, SC; Zhang, ZH | 1 |
| Chang, Y; Fu, X; Jia, S; Li, L; Li, W; Li, X; Li, Z; Ma, W; Ma, Y; Nan, F; Qin, Y; Su, L; Sun, Z; Wang, G; Wang, J; Wang, X; Wu, J; Xue, H; Yan, J; Young, KH; Zhang, D; Zhang, L; Zhang, M; Zhang, X | 1 |
| Cao, J; Fan, S; Jia, S; Li, S; Li, Z; Nan, F; Su, L; Wang, J; Xue, H; Zhang, C; Zhang, L; Zhang, M | 1 |
| Li, L; Wei, W; Wu, P; Zhang, ZH | 1 |
| Farid, M; Koo, GC; Lim, ST; Loong, S; Quek, R; Tao, M; Tay, K; Yau, YW | 1 |
| Chen, XQ; Li, YJ; Wang, KF; Wang, L; Wang, ZH; Xia, YF; Xia, ZJ | 1 |
| Ahn, HK; Hwang, DW; Kim, SJ; Kim, WS; Ko, YH; Lim, ST; Tang, T | 1 |
6 trial(s) available for gemcitabine and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prospective Studies; Survival Rate; Young Adult | 2020 |
Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T-cell lymphoma: A randomized, controlled, open-label, multicenter study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Polyethylene Glycols; Progression-Free Survival; Young Adult | 2021 |
Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.
Topics: Adult; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Recurrence; Risk; Safety; Treatment Outcome | 2018 |
Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols | 2015 |
DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Young Adult | 2016 |
Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Polyethylene Glycols; Young Adult | 2016 |
31 other study(ies) available for gemcitabine and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4.
Topics: Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Interleukin-10; Lymphoma, Extranodal NK-T-Cell; Multidrug Resistance-Associated Proteins | 2022 |
Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters.
Topics: Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Standard of Care | 2023 |
Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply.
Topics: Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Standard of Care | 2023 |
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2023 |
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Etoposide; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Neoplasm Staging; Treatment Outcome | 2023 |
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
Topics: Aminopyridines; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Prospective Studies; Retrospective Studies | 2023 |
sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.
Topics: Antineoplastic Agents; Asparaginase; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Extranodal NK-T-Cell; Neoplasm Proteins | 2020 |
Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Epstein-Barr Virus Infections; Gemcitabine; Herpesvirus 4, Human; Humans; Inhibitory Concentration 50; Lymphoma, Extranodal NK-T-Cell; Mice; Thymalfasin; Viral Load; Xenograft Model Antitumor Assays | 2021 |
[Analysis of Clinical Efficacy and Influencing Factors of Gemcitabine-L-Asparaginase-Oxaliplatin Chemotherapy Scheme and Radiotherapy for Treatment of Early ENKTL Patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Treatment Outcome | 2017 |
Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Female; Gemcitabine; Humans; Killer Cells, Natural; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Prognosis; Remission Induction; Survival Analysis; T-Lymphocytes; Treatment Outcome; Vomiting | 2018 |
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Prognosis; Risk; Survival Analysis | 2018 |
Combined use of DDGP and IMRT has a good effect on extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cisplatin; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2020 |
Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Prognosis; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Young Adult | 2019 |
Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; Gemcitabine; Humans; Inhibitory Concentration 50; Lymphoma, Extranodal NK-T-Cell; Male; Mice; Xenograft Model Antitumor Assays | 2014 |
Diagnosis of brainstem involvement in NK/T cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; Cisplatin; Deoxycytidine; Dexamethasone; DNA, Viral; Etoposide; Gemcitabine; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Neoplastic Stem Cells; Nose Neoplasms; Ophthalmoplegia; Trigeminal Nerve Diseases; Viral Load | 2014 |
Efficacy of a pegaspargase-based regimen in the treatment of newly-diagnosed extranodal natural killer/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Deoxycytidine; Dexamethasone; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Polyethylene Glycols; Remission Induction | 2014 |
Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term fol
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2014 |
A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Dexamethasone; Etoposide; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Neoplasm Recurrence, Local; Treatment Outcome | 2014 |
Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Cohort Studies; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2014 |
Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrosp
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2015 |
A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pilot Projects; Prognosis; Young Adult | 2015 |
Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2015 |
S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blood Proteins; Calgranulin B; Deoxycytidine; Disease-Free Survival; Enzyme-Linked Immunosorbent Assay; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Orosomucoid; Outcome Assessment, Health Care; Polyethylene Glycols; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Proteome; Proteomics; Young Adult | 2016 |
Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2016 |
The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Natural Killer T-Cells; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Radiotherapy; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 2017 |
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Organoplatinum Compounds; Oxaliplatin; Pyrazines; Treatment Outcome | 2011 |
First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma.
Topics: Adult; Aged; Aluminum Hydroxide; Antineoplastic Combined Chemotherapy Protocols; Bentonite; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Magnesium Hydroxide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Skin Neoplasms; Survival Rate | 2013 |